{"ModuleTitle": "Company Description", "CompanyName": "Five Prime Therapeutics, Inc.", "Symbol": "FPRX", "Address": "111 OYSTER POINT BOULEVARD, SOUTH SAN FRANCISCO, California, 94080, United States of America", "Phone": "415-365-5600", "Industry": "Major Pharmaceuticals", "Sector": "Health Care", "Region": "North America", "CompanyDescription": "We are a clinical-stage biotechnology company focused on developing immune\r\nmodulators and precision therapies to improve the lives of patients with solid\r\ntumor cancers. Our primary focus is on developing immuno-oncology and targeted\r\ncancer therapies. Each of our product candidates has an innovative mechanism of\r\naction and addresses patient populations for which better therapies are needed.\r\nIn addition, we use companion diagnostics where appropriate to allow us to\r\nselect patients most likely to benefit from treatment with our product\r\ncandidates. The most advanced product candidates that we or our partners are\r\ndeveloping are identified below.&nbsp;&nbsp;... <a href=\"http://secfilings.nasdaq.com/edgar_conv_html%2f2020%2f02%2f27%2f0001564590-20-007407.html#FIS_BUSINESS\" target=\"_blank\">More</a> ...&nbsp;&nbsp;\r\n", "KeyExecutives": [{"name": "David V. Smith", "title": "Chief Financial Officer & Executive Vice President"}, {"name": "Helen Collins", "title": "Chief Medical Officer & Executive Vice President"}, {"name": "Tom Civik", "title": "President, Chief Executive Officer & Director"}], "Number_of_employees": ["NO INFO"], "Subsidiaries": ["NO INFO"]}